Obesity and periodontitis are chronic inflammatory diseases that share common pathological mechanisms. Asprosin, a novel adipokine discovered in 2016, has not been extensively studied in relation to periodontal tissues. In our study, we investigate the levels of asprosin in both serum and gingival crevicular fluid of patients with obesity and those of normal weight who have periodontitis. Additionally, our research aims to clarify the pathophysiological mechanisms linking periodontitis and obesity by examining local and systemic levels of TNF-α, IL-6, and asprosin, alongside clinical periodontal parameters.
Study Type
OBSERVATIONAL
Enrollment
60
Participants are not assigned an intervention as part of the study.
Gazi University Faculty of Dentistry
Ankara, Turkey (Türkiye)
Biyomarker levels
All groups' GCF and serum levels of asprosin, TNF-α, and IL-6 levels
Time frame: 08.10.2023-08.10.2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.